Therapeutic nucleic acids—lab-created segments of DNA
or RNA, designed be used to block or modify genes, control gene
expression or regulate other cellular processes—are a promising but
still emerging area of biomedical treatment, with several drugs
already in use and many more in trials. Nucleic acid nanoparticles
(NANPs) are programmable assemblies made exclusively of nucleic
acids with a number of therapeutic nucleic acid sequences embedded
in their structure in a specific configuration, designed for the
packaging and delivery of a number of intercellular or
extracellular treatments simultaneously, to cause multiple,
therapeutic actions human cells.
New test method to standardize immunological evaluation of
nucleic acid nanoparticles
